The Decade of Vaccine Economics (DOVE) project at IVAC-JHSPH published a new methodology report, developed collaboratively with DOVE-ROI Core Advisory Group members from 9 institutions to support Gavi’s mid-term review and investment case.
Did you know that the models developed by the DOVE project estimate the costs averted by vaccination? The models focuses on ten antigens and 94 low- and middle-income countries, 2001-2030. Results are used at the global and regional level to advocate for new vaccine introduction and increased coverage.
Pneumonia, Diarrhea, and Measles force Bangladeshi households to make difficult financial decisions when illnesses arise. The Decade of Vaccine Economics study continues to shed light on the importance of preventing common childhood illness. Read more here
Local engagement and empowerment have been essential for the DOVE study to develop cost of illness estimates and apply them to policymaking and program planning in Uganda. Here are some ideas and tools you can use...
Research helps stakeholders in Bangladesh and other countries make more informed decisions about the true economic burden of childhood diseases and better evaluate investments in vaccines. Read more here